Final Evidence Report and Meeting Summary
New England CEPAC

PDF cover

Obeticholic Acid: Final Evidence Report (NASH)

ICER’s final report reviewing the comparative clinical effectiveness and value of obeticholic acid for treatment of nonalcoholic steatohepatitis. This report includes a summary of a public meeting of the New England Comparative Effectiveness Public Advisory Council, during which the independent Council deliberated and voted on evidence presented in the report and discussed the implications of their votes with a policy roundtable of experts field to develop recommendations to guide policy and practice.


View All Materials on this Topic or Go Back to View More Materials